Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-708-3p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 123, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
MPL hsa-miR-708-3p low: 2 high: 0 1 2 1 -
Low-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Michael Girardot et al. 2010 WB Bone Marrow MO7E N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
Michael Girardot et al. 2010 RP Bone Marrow HEL MO7E N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
N4BP1 hsa-miR-708-3p low: 1 high: 0 1 2 2 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Michael Girardot et al. 2010 RP Bone Marrow HEL JAK2 N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Michael Girardot et al. 2010 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
ACTB hsa-miR-708-3p low: 1 high: 0 1 1 1 -
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Michael Girardot et al. 2010 WB Bone Marrow MO7E N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot NEGATIVE INDIRECT TarBase 7.0
MAPK1 hsa-miR-708-3p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Michael Girardot et al. 2010 RP Bone Marrow HEL JAK2 N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
TEX261 hsa-miR-708-3p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Michael Girardot et al. 2010 RP Bone Marrow HEL MO7E N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
OTUB1 hsa-miR-708-3p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Michael Girardot et al. 2010 RP Bone Marrow HEL MO7E N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
E2F6 hsa-miR-708-3p low: 1 high: 0 1 1 1 -
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Michael Girardot et al. 2010 RP Bone Marrow HEL JAK2 N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay NEGATIVE DIRECT TarBase 7.0
CA2 hsa-miR-708-3p low: 0 high: 2 1 1 1 0.677
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr8:85480874-85480895 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr8:85480874-85480895 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EFR3A hsa-miR-708-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr8:132011516-132011533 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr8:132011516-132011533 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BCL2L11 hsa-miR-708-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr2:111166728-111166754 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:111166728-111166754 HITS-CLIP POSITIVE DIRECT TarBase 7.0
THY1 hsa-miR-708-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr11:119419162-119419183 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:119419162-119419183 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KLHL15 hsa-miR-708-3p low: 0 high: 1 4 2 2 0.487
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chrX:23986330-23986357 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Hafner M. et al. 2010 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
Sebastian Memczak et al. 2013 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
Kishore S et al. 2011 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
CYP51A1 hsa-miR-708-3p low: 0 high: 1 1 1 1 0.536
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr7:92112930-92112937 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FKBP4 hsa-miR-708-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:2800439-2800461 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF207 hsa-miR-708-3p low: 0 high: 1 1 1 1 0.611
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr17:32380369-32380388 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUDCD3 hsa-miR-708-3p low: 0 high: 1 1 1 1 0.592
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:44384421-44384443 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RUNX3 hsa-miR-708-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:24900193-24900220 HITS-CLIP POSITIVE DIRECT TarBase 7.0
VIM hsa-miR-708-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr10:17237446-17237468 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DCUN1D1 hsa-miR-708-3p low: 0 high: 1 1 1 1 0.722
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr3:182944656-182944672 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SEC61A2 hsa-miR-708-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr10:12161087-12161107 HITS-CLIP POSITIVE DIRECT TarBase 7.0